Moderate to advanced glaucoma Trabeculectomy Glaucoma Medication Cost effectiveness Quality of life
Conditions
Interventions
Arm 1 receives initial trabeculectomy,
the glaucoma procedure.,Arm 2 receives only medication,
which will be adjusted the numbers and dosages by clinical changes.
Trabeculectomy,Medication
Sponsors
็Health systems research institute
็Health systems research institute
Eligibility
Sex/Gender
All
Age
25 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Newly diagnosed (within 3 months) glaucoma which is one of the followings: primary open angle glaucoma or pseudo exfoliation glaucoma or primary angle closure glaucoma that was underwent laser iridotomy and had visible trabecular meshwork at least 180 degrees. 2. Initial intraocular pressure at least 20 mmHg 3. Visual field mean deviation less than -6 dB 4. Able to have regular follow up schedule
Exclusion criteria
Exclusion criteria: 1. history of any intraocular surgery except for uncomplicated phacoemulsification with IOL for more than 3 months. 2. active intraocular inflammation 3. history of eye trauma 4. current or anticipated (in 1 year) pregnancy 5. allergy to sulfonamide 6. uncooperated patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraocular pressure 1 year Goldman tonometer | — |
Secondary
| Measure | Time frame |
|---|---|
| quality of life 1 year NEI-VEQ25,cost effectiveness 1 year EQ5D5L | — |
Countries
Thailand
Contacts
Public ContactPrin Rojanapongpun
Chulalongkorn university
Outcome results
None listed